T-cell non-Hodgkin lymphoma. Blood. 2006; 107 :1255–1264.Rizvi MA, Evens AM, Tallman MS, et al. T-cell non-Hodgkin lymphoma. Blood. 2006;107:1255-64.Rizvi MA, Evens AM, Tallman MS, Nelson BP, Rosen ST. T-cell non-Hodgkin lymphoma. Blood. 2006; 107 :1255–1264. doi: ...
1. Background: T-cell non-Hodgkin lymphoma (T-NHL) is a complex and heterogeneous group of malignancies characterized as lymphoproliferative disorders. 背景:T细胞非霍奇金淋巴瘤(T-NHL)具有高度异质性,分类复杂,临床表现各异。更多例句>> 2) B cell non-Hodgkin's lymphoma B细胞非霍奇金淋巴瘤 1....
1) Non-Hodgkin's lymphoma T-非霍奇金淋巴瘤 2) t-T t-T 1. Objective To study the clinical effect of T wave transient change(T wave change from upright to inversion,then upright again,t-T)by routine12leads of electrocardiogram.
The diagnosis of the syndrome of inappropriate antidiuretic hormone secretion as a presenting symptom of non-Hodgkin's T-cell lymphoma (needle biopsy) was made. In spite of intensive chemotherapy, and although hyponatremia did not recur, the clinical course was stormy, her condition deteriorated ...
Leuk LymphomaBattig B: T-cell rich B-cell non-Hodgkin's lymphoma mimicking Hodgkin's disease. Leukemia and Lympho- ma 33:393-398, 1999Battig B, Mueller-Garamvoelgyi E, Cogliatti SB, Schmid U, Kappeler A, Cerny T, et al. T-cell-rich B-cell non-Hodgkin's lymphoma mimicking Hodgkin...
CAR T细胞疗法最初是针对某些类型的血液肿瘤,特别是急性淋巴细胞性白血病(Acute Lymphoblastic Leukemia, ALL)和非霍奇金淋巴瘤(Non-Hodgkin Lymphoma, NHL)。这种疗法在一些临床试验中显示出非常有希望的结果。例如,在对于难治性或复发性ALL的儿童和成...
Objective To investigate the clinical feature and treatment options of primary nasal cavity T-cell non-Hodgkin lymphoma(NHL). Methods From January 1997 to December 2001,34 patients primary nasal cavity T-cell NHL were treated in our hospital. Twenty three patients were treated by chemotherapy plus...
T-cell rich B-cell non-Hodgkin's lymphoma (T-cell rich B-cell lymphoma) is a morphological variant of diffuse large B-cell lymphoma. It is important to recognize this variant in the differential diagnosis of T-cell non-Hodgkin's lymphoma. The main differential diagnosis of T-cell rich B...
CAR T-Cell Therapy in Non-Hodgkin Lymphoma Patients Oncology (08909091)Copelan, Edward A.
[16] Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s Lymphoma. Retrieved March 7, 2024 from https://markets.ft.com/data/announce/detail?dockey=600-202403060100BIZWIRE_USPRX___20240305_BW907062-1 [...